Sonja Dakić

Dr. Sonja Dakić


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2014 in Open Medicine
Verified
Journal Article
Open access
GKGoran P. Koraćević
Goran P. Koraćević
SDSonja Dakić
Sonja Dakić
RVRadmila M. Veličković-Radovanović
Radmila M. Veličković-Radovanović
SASvetlana Apostolovic
Svetlana Apostolovic
NKNebojša H. Krstić
Nebojša H. Krstić
TKTomislav L. Kostić
Tomislav L. Kostić
European Society of Cardiology Guidelines cite results of meta-analysis that the use of calcium channel blockers results in fewer angina episodes per week vs. long-acting nitrates. Moreover, we listed 12 reasons more to prefer amlodipine over long-acting nitrates, especially in stable angina pectoris patients with arterial hypertension. It may be the way to decrease polypharmacy without loosing efficacy. Some important advantages of amlodipine versus long-acting nitrate (s) are: amlodipine also treats hypertension, it helps reducing hypertensive target organ damages (e.g. left ventricular hypertrophy) and prevents morning blood pressure surge. Moreover, amlodipine can be given once daily (which improves adherence), it produces neither tolerance nor rebound, it has less side effects.

1 July 2019
Verified
Closed access
GKG. Koracevic
G. Koracevic
MPM. Pavlovic
M. Pavlovic
DSD. Stanojevic
D. Stanojevic
TKT. Kostic
T. Kostic
RVR. Velickovic-Radovanovic
R. Velickovic-Radovanovic
SPS. Petrovic
S. Petrovic

22 June 2026 in Medicina
Verified
Journal Article
Open access
PDF file
SDSonja Dakić
Sonja Dakić
ZPZoran Perišić
Zoran Perišić
SASvetlana Apostolovic
Svetlana Apostolovic
TKTomislav Kostić
Tomislav Kostić
GKGoran Koraćević
Goran Koraćević
TFTamara Dušan Filipović
Tamara Dušan Filipović
Background and Objectives: Ticagrelor reduces ischemic events in acute coronary syndrome (ACS) but increases bleeding risk. Clinical predictors of bleeding are well established; the contribution of cytochrome P450 polymorphisms involved in ticagrelor metabolism remains uncertain, with conflicting reports in the literature. We examined the association of CYP3A4* 22 (rs 35599367), CYP3A5* 3 (rs 776746), and CYP4F2 (rs3093135) with bleeding in a Serbian ACS cohort. Materials and Methods: This prospective, single- center observational study enrolled 105 consecutive ACS patients undergoing percutaneous coronary intervention (PCI) or medical management after coronary angiography and receiving dual antiplatelet therapy (DAPT) with acetylsalicylic acid and ticagrelor at the University Clinical Center Niš between January 2024 and the end of May 2025. Bleeding events occurring during the index hospitalization and the six-month follow-up were classified according to the Bleeding Academic Research Consortium (BARC) criteria. Genotyping used TaqMan assays. Associations with bleeding were assessed using Firth’s penalized logistic regression, with multivariable adjustment for age and renal function. Severity-stratified analyses and gradient-boosted machine learning (XGBoost with SHAP) were performed as exploratory analyses. Results: Thirteen patients (12.4%) experienced bleeding (nine minor [BARC 1/2], four major [BARC 3/5]). Age ≥ 75 years (univariable OR 7.62, p = 0.001) and eGFR < 60 mL/min/1. 73 m 2 (OR 3.68, p = 0.006) were the strongest predictors. CYP3A5 *1 carrier status was univariably associated with bleeding (OR 4.16, p = 0.043) but did not remain significant after adjustment for age and renal function, and *1 carriers were significantly older and more likely to have impaired renal function. No genotype was associated with major (BARC 3/5) bleeding. The apparent effect was concentrated in minor bleeding (BARC 1/2 rate: 30.8% versus 5.5%), with no major events among *1 carriers. CYP 3 A 4* 22 (OR 1.37, p = 0.109) and CYP 4 F 2 (OR 1.17, p = 0.111) showed no association. Machine-learning analyses confirmed eGFR and age as the dominant predictors. Conclusions: In this Serbian ACS cohort, clinical factors—particularly advanced age and impaired renal function—dominated the prediction of bleeding risk. The CYP3A5 signal was largely explained by baseline imbalances in age and renal function. CYP 3 A 4* 22 and CYP 4 F 2 polymorphisms did not contribute additional predictive information. Preemptive genotyping for these variants is unlikely to materially improve bleeding-risk assessment beyond standard clinical evaluation in patients of this type.

11 November 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DSDragana M. Stanojevic
Dragana M. Stanojevic
SASvetlana Apostolovic
Svetlana Apostolovic
SIStefan Ilić
Stefan Ilić
BMBojan Maričić Bojan Maričić
Bojan Maričić Bojan Maričić
SDSonja Dakić
Sonja Dakić
JSJelena Stanojevic
Jelena Stanojevic
Background/Objectives: Older adults with acute coronary syndrome (ACS) are clinically heterogeneous, and treatment decisions should not rely on chronological age alone. We examined associations of age and clinical vulnerability with coronary angiography, subsequent percutaneous coronary intervention (PCI), and mortality in patients aged ≥75 years. Methods: We retrospectively studied 1043 consecutive patients hospitalized with ACS between January 2021 and April 2026. Clinical vulnerability was assessed using the exploratory, study-specific Senior ACS Clinical Vulnerability Score (SAF-75). Results: Mean age was 81.0 years; 47.6% were women. Coronary angiography was performed in 571 patients (54.7%) and PCI in 208 (19.9%). Angiography declined from 68.6% at age 75–79 years to 30.1% at ≥85 years. Age was independently associated with lower odds of angiography (OR 0.86 per year, 95% CI 0.82–0.89; p < 0.001), but not with subsequent PCI among patients undergoing angiography (OR 1.01, 95% CI 0.95–1.06; p = 0.852). In-hospital and Kaplan–Meier estimated 1-year mortality were 18.1% and 35.7%. Greater vulnerability was associated with lower angiography use and higher mortality; no independent association with PCI after angiography was detected. Conclusions: Age-related and vulnerability-related differences were most evident at angiography selection. SAF-75 was strongly associated with prognosis but requires external validation.